資料下載
測(cè)量應(yīng)用案例-20190908
閱讀:146 發(fā)布時(shí)間:2019-9-24提 供 商 | 美國布魯克海文儀器公司 | 資料大小 | 1.7MB |
---|---|---|---|
資料圖片 | 下載次數(shù) | 63次 | |
資料類型 | PDF 文件 | 瀏覽次數(shù) | 146次 |
免費(fèi)下載 | 點(diǎn)擊下載 |
文獻(xiàn)名: Mesoporous NiS2 nanospheres as a hydrophobic anticancer drug delivery vehicle for synergistic photothermal–chemotherapy
作者: Gang He a, Yan Ma a, Hu Zhou b, Siyuan Sun a, Xianwen Wang a, Haisheng Qian a, Yan Xu a, Zhaohua Miao a and Zhengbao Zha a
aSchool of Food and Biological Engineering, Hefei University of Technology, Hefei, Anhui 230009, P. R. China.
bThe First Affiliated Hospital of University of Science and Technology of China, Anhui Provincial Cancer Hospital, Hefei, Anhui 230001, P. R. China
摘要:To overcome the unfavorable effects of the hydrophobicity of drugs and cancer resistance, mesoporous NiS2 nanospheres (mNiS2 NSs) have been successfully developed here to package hydrophobic camptothecin (CPT) and realize the synergistic photothermal–chemotherapy of cancer. The mNiS2 NSs which were prepared through a facile solvothermal method here exhibited not only considerable near-infrared (NIR) absorption and good photothermal conversion efficiency as high as 44.6%, but also achieved a NIR light induced CPT release property which were both beneficial for improving the cancer cell-killing efficacy. After a short period of NIR light illumination, a significant intensified cell killing efficacy was observed when 4T1 or HepG2 cancer cells were incubated with CPT@mNiS2 NSs. Thus, mNiS2 NSs have been demonstrated here to have potential as a novel NIR light-responsive hydrophobic drug delivery nanoplatform for realizing synergistic cancer treatment.